InflaRx NV
NASDAQ:IFRX
InflaRx NV
Cash from Financing Activities
InflaRx NV
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
InflaRx NV
NASDAQ:IFRX
|
Cash from Financing Activities
€53m
|
CAGR 3-Years
79%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Cash from Financing Activities
-€778.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Cash from Financing Activities
€43m
|
CAGR 3-Years
-64%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-11%
|
|
Immatics NV
NASDAQ:IMTX
|
Cash from Financing Activities
€84.5m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Cash from Financing Activities
-€6.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
43%
|
CAGR 10-Years
N/A
|
|
Formycon AG
XETRA:FYB
|
Cash from Financing Activities
€40.7m
|
CAGR 3-Years
33%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
See Also
What is InflaRx NV's Cash from Financing Activities?
Cash from Financing Activities
53m
EUR
Based on the financial report for Dec 31, 2023, InflaRx NV's Cash from Financing Activities amounts to 53m EUR.
What is InflaRx NV's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
1%
Over the last year, the Cash from Financing Activities growth was 2 631%. The average annual Cash from Financing Activities growth rates for InflaRx NV have been 79% over the past three years , 1% over the past five years .